
Bank of America spends $250M yearly on GLP-1 weight loss drugs for employees, seeing it as a health investment.
Bank of America CEO Brian Moynihan revealed the company spends over $250 million annually on GLP-1 weight loss medications for its 211,000 employees, a cost that has risen from zero five years ago. This expense now accounts for about 13% of the bank'...


